Novel Anti-CRR9/CLPTM1L antibodies with antitumorigenic activity inhibit cell surface accumulation, PI3K interaction, and survival signaling

László G. Puskás, Imola Mán, Gabor Szebeni, László Tiszlavicz, Susan Tsai, Michael A. James

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Novel Anti-CRR9/CLPTM1L antibodies with antitumorigenic activity inhibit cell surface accumulation, PI3K interaction, and survival signaling'. Together they form a unique fingerprint.

Medicine & Life Sciences